Corpus Intelligence IC Memo — BEAUFORT MEMORIAL HOSPITAL 2026-04-26 04:04 UTC
IC Memo — BEAUFORT MEMORIAL HOSPITAL
Investment Committee Memorandum | SC | 167 beds | Grade B | EBITDA uplift $19.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEAUFORT MEMORIAL HOSPITAL

CCN 420067 | BEAUFORT, SC | 167 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

BEAUFORT MEMORIAL HOSPITAL is a 167-bed suburban community hospital in BEAUFORT, SC with $269.0M in net patient revenue and a -7.3% operating margin. The hospital serves a payer mix of 31.1% Medicare, 6.7% Medicaid, and 62.2% commercial.

Thesis: Undervalued. Our ML models identify $19.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.3% to 0.1% (+736bps).

Net Revenue HCRIS$269.0M
Current EBITDA COMPUTED$-19.6M
Operating Margin COMPUTED-7.3%
Occupancy HCRIS54.1%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS27.4%
Distress Probability ML47.3%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
27
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -7.3% places it below the state median. Among 27 size-comparable peers (84-334 beds), the median margin is 0.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-334), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEAUFORT MEMORIAL HOSPITAL (Target)SC167$269.0M-7.3%
ST. FRANCIS HOSPITAL INCSC327$691.4M4.9%
SELF REGIONAL HEALTHCARESC290$410.1M4.7%
ROPER HOSPITAL INC.SC266$400.8M-3.0%
BON SECOURS ST. FRANCIS XAVIERSC186$304.6M12.2%
PRISMA HEALTH BAPTIST HOSPITALSC246$277.5M0.4%
MCLEOD LORIS SEACOAST HOSPITALSC155$262.3M10.1%
MUSC HEALTH FLORENCE MEDICAL CSC187$252.9M-6.9%
CONWAY HOSPITALSC171$250.2M-14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.6M+210bp18mo
Cost to Collect4.5%2.5%$5.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.3M+122bp9mo
Clean Claim Rate88.0%96.0%$172K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.6M
Cost to Collect
$5.4M
Denial Rate Reduction
$5.3M
A/R Days Reduction
$3.3M
Clean Claim Rate
$172K
Total EBITDA Uplift$19.8M
Current EBITDA$-19.6M
+ RCM Uplift+$19.8M
Pro Forma EBITDA$196K
Current Margin-7.3%
Pro Forma Margin0.1%
WC Released (1x)$10.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-30.2M$68.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-30.2M$65.8M0.00x-100.0%
Bull Case9.0x11.0x$-27.1M$121.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-27.1M$124.3M0.00x-100.0%
Bear Case11.0x10.0x$-33.2M$-20.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-33.2M$-33.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 84-334 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-12.6% / P50=0.2% / P75=9.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.